Article Details

Non-Alcoholic Steatohepatitis (NASH) Drugs Market Innovative Strategy by 2030

Retrieved on: 2022-07-25 08:58:25

Tags for this article:

Click the tags to see associated articles and topics

Non-Alcoholic Steatohepatitis (NASH) Drugs Market Innovative Strategy by 2030. View article details on hiswai: https://www.thisisardee.ie/2022/07/25/non-alcoholic-steatohepatitis-nash-drugs-market-innovative-strategy-by-2030-astrazeneca-conatus-pharmaceuticals-enzo-biochem/

Excerpt

8 Key players- AstraZeneca, Conatus Pharmaceuticals, Enzo Biochem, Galmed Pharmaceuticals, Genfit, Gilead, Horizon Pharma, Immuron, Intercept ...

Article found on: www.thisisardee.ie

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up